Do Implantable Cardioverter-Defibrillators (ICDs) have pacing capabilities?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Do ICDs Have Pacing Capabilities?

Yes, most implantable cardioverter-defibrillators (ICDs) have pacing capabilities, including both bradycardia support pacing and antitachycardia pacing (ATP) for terminating ventricular tachyarrhythmias without delivering painful shocks. 1

Types of Pacing in ICDs

Bradycardia Support Pacing

  • All modern ICDs incorporate programmable ventricular demand pacing to support patients with bradycardia 1
  • Pacing rates can be programmed according to patient needs
  • For patients without bradycardia indications, backup pacing rates can be set very low (30-40 bpm) to minimize unnecessary ventricular pacing 1

Antitachycardia Pacing (ATP)

  • ATP uses pacing stimulation techniques to terminate tachyarrhythmias, particularly ventricular tachycardia (VT) 1
  • Studies show ATP can terminate approximately 85-90% of slow VTs and a high percentage of fast VTs 1
  • ATP provides painless termination of VT, improving quality of life by reducing the need for painful shocks 1
  • The addition of ATP functionality increases device cost by only 5-10% 1

Advanced Pacing Options

  • Dual-chamber ICDs incorporate atrial leads that provide:
    • Dual-chamber pacing capabilities
    • Enhanced discrimination between supraventricular and ventricular arrhythmias 1
  • Cardiac resynchronization therapy defibrillators (CRT-D) provide biventricular pacing for heart failure patients 1

Clinical Applications of ICD Pacing

Primary Indications for Pacing in ICD Recipients

  1. Bradycardia support: For patients with sinus node dysfunction or AV block 1
  2. Termination of ventricular tachyarrhythmias: ATP successfully terminates VT in most cases 1, 2
  3. Cardiac resynchronization: For heart failure patients with ventricular dyssynchrony 1

Special Considerations

  • In patients requiring permanent pacing who also meet ICD criteria, a device with appropriate pacing capabilities is recommended rather than separate devices 1
  • In hypertrophic cardiomyopathy patients with ICDs, 46% benefit from the pacing functions 2
  • ATP successfully terminates 77% of monomorphic VT episodes without requiring shocks 2

Important Caveats and Limitations

Potential Adverse Effects of Pacing

  • Right ventricular apical pacing may worsen heart failure in some patients 1
  • Unnecessary ventricular pacing can lead to:
    • Reduced ventricular systolic function
    • Mechanical dyssynchrony
    • Increased risk of atrial fibrillation 1

Device Selection Considerations

  • Subcutaneous ICDs (S-ICDs) do NOT provide bradycardia pacing or ATP and should not be used in patients requiring these functions 1
  • S-ICDs only provide limited post-shock bradycardia pacing 1
  • For patients with anticipated pacing needs, transvenous ICDs are appropriate 1

Algorithm for ICD Selection Based on Pacing Needs

  1. Patient requires bradycardia pacing or has AV block:

    • Choose transvenous ICD with appropriate pacing capabilities
    • Consider dual-chamber ICD if atrial pacing is needed
  2. Patient has history of monomorphic VT:

    • Select ICD with ATP capabilities (most modern ICDs)
  3. Patient has heart failure with ventricular dyssynchrony:

    • Choose CRT-D device for biventricular pacing
  4. Patient has no anticipated pacing needs:

    • Consider either transvenous ICD (with minimal backup pacing) or subcutaneous ICD
  5. Patient has high infection risk but needs pacing:

    • Transvenous ICD is still required despite infection risk 1

In summary, modern ICDs provide multiple pacing modalities beyond their primary defibrillation function, making them versatile devices for managing both bradyarrhythmias and tachyarrhythmias in at-risk patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Benefits of cardiac pacing in ICD recipients with hypertrophic cardiomyopathy.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.